Amalgamated Bank’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,947
| Closed | -$1.47M | – | 2991 |
|
|
2025
Q2 | $1.47M | Sell |
14,947
-269
| -2% | -$25.5K | 0.01% | 898 |
|
|
2025
Q1 | $1.41M | Sell |
15,216
-377
| -2% | -$34.8K | 0.01% | 909 |
|
|
2024
Q4 | $1.42M | Buy |
15,593
+444
| +3% | +$40.8K | 0.01% | 914 |
|
|
2024
Q3 | $1.46M | Sell |
15,149
-3,371
| -18% | -$329K | 0.01% | 925 |
|
|
2024
Q2 | $1.7M | Sell |
18,520
-3,438
| -16% | -$319K | 0.01% | 885 |
|
|
2024
Q1 | $2.02M | Buy |
21,958
+1,574
| +8% | +$148K | 0.02% | 851 |
|
|
2023
Q4 | $1.94M | Sell |
20,384
-126
| -0.6% | -$11.8K | 0.02% | 927 |
|
|
2023
Q3 | $1.92M | Sell |
20,510
-679
| -3% | -$62.7K | 0.02% | 882 |
|
|
2023
Q2 | $1.94M | Sell |
21,189
-1,051
| -5% | -$86.2K | 0.02% | 901 |
|
|
2023
Q1 | $1.64M | Sell |
22,240
-4,859
| -18% | -$420K | 0.01% | 939 |
|
|
2022
Q4 | $2.26M | Buy |
27,099
+3,919
| +17% | +$353K | 0.02% | 852 |
|
|
2022
Q3 | $2.24M | Buy |
23,180
+541
| +2% | +$64.5K | 0.02% | 790 |
|
|
2022
Q2 | $2.38M | Sell |
22,639
-1,416
| -6% | -$181K | 0.02% | 802 |
|
|
2022
Q1 | $4.14M | Sell |
24,055
-97
| -0.4% | -$14.5K | 0.03% | 576 |
|
|
2021
Q4 | $3.91M | Buy |
24,152
+727
| +3% | +$117K | 0.03% | 647 |
|
|
2021
Q3 | $3.49M | Sell |
23,425
-2,411
| -9% | -$501K | 0.03% | 687 |
|
|
2021
Q2 | $6.33M | Buy |
25,836
+19,594
| +314% | +$5.14M | 0.05% | 404 |
|
|
2021
Q1 | $1.65M | Sell |
6,242
-519
| -8% | -$146K | 0.06% | 310 |
|
|
2020
Q4 | $1.98M | Buy |
6,761
+108
| +2% | +$27.7K | 0.08% | 243 |
|
|
2020
Q3 | $1.57M | Sell |
6,653
-182
| -3% | -$41.4K | 0.07% | 274 |
|
|
2020
Q2 | $1.36M | Buy |
6,835
+944
| +16% | +$176K | 0.06% | 292 |
|
|
2020
Q1 | $1.08M | Sell |
5,891
-188
| -3% | -$33.4K | 0.03% | 591 |
|
|
2019
Q4 | $1.01M | Buy |
6,079
+274
| +5% | +$40.8K | 0.02% | 797 |
|
|
2019
Q3 | $761K | Sell |
5,805
-101
| -2% | -$13.1K | 0.02% | 852 |
|
|
2019
Q2 | $717K | Buy |
5,906
+1,587
| +37% | +$188K | 0.02% | 893 |
|
|
2019
Q1 | $532K | Buy |
4,319
+113
| +3% | +$14.2K | 0.01% | 968 |
|
|
2018
Q4 | $493K | Buy |
4,206
+2,344
| +126% | +$276K | 0.01% | 931 |
|
|
2018
Q3 | $233K | Sell |
1,862
-2,805
| -60% | -$310K | 0.01% | 1246 |
|
|
2018
Q2 | $399K | Buy |
4,667
+563
| +14% | +$41.3K | 0.01% | 1149 |
|
|
2018
Q1 | $248K | Sell |
4,104
-64
| -2% | -$3.65K | 0.01% | 1328 |
|
|
2017
Q4 | $220K | Buy |
4,168
+252
| +6% | +$13.3K | 0.01% | 1442 |
|
|
2017
Q3 | $219K | Sell |
3,916
-4
| -0.1% | -$212 | 0.01% | 1396 |
|
|
2017
Q2 | $246K | Buy |
+3,920
| New | +$228K | 0.01% | 1306 |
|
Other funds holding AMED
IA
MCI
HNB
Amalgamated Bank's AMED Position: Q3 2025 in Review
Amalgamated Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 14,947 shares — an estimated $1.47M sold.
Amalgamated Bank first reported a position in AMED in Q2 2017 and held it in 33 quarters. The position peaked at $6.33M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Amalgamated Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Amalgamated Bank sold 14,947 Amedisys shares in Q3 2025, an estimated $1.47M.
- Amalgamated Bank first reported a position in Amedisys in Q2 2017 and held it in 33 quarters.
- Amalgamated Bank's Amedisys position peaked at $6.33M in Q2 2021.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Amalgamated Bank's 13F filing for Q3 2025, filed 29 Oct 2025.